These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Compliance to hormone replacement therapy. Rozenberg S, Vandromme J, Kroll M, Pastijn A, Liebens F. Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():23-32. PubMed ID: 7581586 [Abstract] [Full Text] [Related]
23. [Benefits and risks in hormone substitute therapy in postmenopause]. Baljić T. Srp Arh Celok Lek; 1996; 124(5-6):143-6. PubMed ID: 9102835 [Abstract] [Full Text] [Related]
30. Current status of hormone therapy and breast cancer. Norman RJ, MacLennan AH. Hum Reprod Update; 2005 Sep; 11(6):541-3. PubMed ID: 16150811 [Abstract] [Full Text] [Related]
31. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE. Acta Endocrinol (Copenh); 1991 Sep; 125 Suppl 1():13-26. PubMed ID: 1801500 [Abstract] [Full Text] [Related]
32. Hormone therapy and breast cancer risk. Foidart JM, Desreux J, Pintiaux A, Gompel A. Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674 [Abstract] [Full Text] [Related]